A Study of Azacitidine and Venetoclax in People With Acute Myeloid Leukemia (AML)

חו"ל (דורש נסיעה)מגייס משתתפיםPHASE2

מצבים רפואיים

Acute Myeloid Leukemia (AML)

סיכום בשפה פשוטהבעזרת בינה מלאכותית

הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.

מיקומים
  • Memorial Sloan Kettering at Basking Ridge (All Protocol Activities), Basking Ridge, New Jersey, United States

    Contact: Study coordinator (Meira Yisraeli Salman, MD) · 646-608-3982
  • Memorial Sloan Kettering Monmouth (All Protocol Activities), Middletown, New Jersey, United States

    Contact: Study coordinator (Meira Yisraeli Salman, MD) · 646-608-3982
  • Memorial Sloan Kettering Bergen (All Protocol Activities), Montvale, New Jersey, United States

    Contact: Study coordinator (Meira Yisraeli Salman, MD) · 646-608-3982
  • Memorial Sloan Kettering Suffolk-Commack (All Protocol Activities), Commack, New York, United States

    Contact: Study coordinator (Meira Yisraeli Salman, MD) · 646-608-3982
  • Memorial Sloan Kettering Westchester (Limited Protocol Activities), Harrison, New York, United States

    Contact: Study coordinator (Meira Yisraeli Salman, MD) · 646-608-3982
  • Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York, New York, United States

    Contact: Study coordinator (Meira Yisraeli Salman, MD) · 646-608-3982
  • Memorial Sloan Kettering Nassau (All Protocol Activities), Rockville Centre, New York, United States

    Contact: Study coordinator (Meira Yisraeli Salman, MD) · 646-608-3982
מובילי המחקר
  • Eytan Stein, MD

    Principal Investigator

    Memorial Sloan Kettering Cancer Center

  • Meira Yisraeli Salman, MD

    Principal Investigator

    Memorial Sloan Kettering Cancer Center